KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $129.9 million.

  • Idexx Laboratories' Depreciation & Amortization (CF) rose 7.31% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.2 million, marking a year-over-year increase of 11.27%. This contributed to the annual value of $129.9 million for FY2024, which is 13.08% up from last year.
  • Per Idexx Laboratories' latest filing, its Depreciation & Amortization (CF) stood at $129.9 million for FY2024, which was up 13.08% from $114.9 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Depreciation & Amortization (CF) ranged from a high of $129.9 million in FY2024 and a low of $96.0 million during FY2020.
  • In the last 3 years, Idexx Laboratories' Depreciation & Amortization (CF) had a median value of $114.9 million in 2023 and averaged $118.9 million.
  • Data for Idexx Laboratories' Depreciation & Amortization (CF) shows a peak YoY climbed of 13.08% (in 2024) over the last 5 years.
  • Idexx Laboratories' Depreciation & Amortization (CF) (Yearly) stood at $96.0 million in 2020, then increased by 8.96% to $104.6 million in 2021, then rose by 6.98% to $111.9 million in 2022, then climbed by 2.69% to $114.9 million in 2023, then rose by 13.08% to $129.9 million in 2024.